Published on : 06 Oct 2025, 11:38 am Summary

New guidelines from WHO, FIGO and ICM aim to revolutionise the prevention, diagnosis and treatment of postpartum haemorrhage (PPH), a leading cause of maternal mortality.

Based on a major Lancet study, the guidelines introduce objective diagnostic criteria.

They also recommend the E-MOTIVE bundle for immediate action, aiming to save lives and reduce global health disparities.

On October 5, 2025, leading reproductive health organisations issued new guidelines advocating for significant changes in the prevention, diagnosis and treatment of postpartum hemorrhage (PPH).

The guidelines were published by the World Health Organization (WHO) , the International Federation of Gynecology and Obstetrics and the International Confederati

See Full Page